Search

Search Results
Results 8231 - 8240 of 8357 for allergy
  • Abacavir/Lamivudine Viatris
    Drug - 12 Jan 2023
    Consumer Medicine Information (CMI) about Abacavir/Lamivudine Viatris intended for persons living in Australia.
  • Voltaren
    Drug - 10 Jan 2023
    Consumer Medicine Information (CMI) about Voltaren (diclofenac sodium) intended for persons living in Australia.
  • Voltaren Rapid
    Drug - 10 Jan 2023
    Consumer Medicine Information (CMI) about Voltaren Rapid (diclofenac potassium) intended for persons living in Australia.
  • Feldene and Feldene-D
    Drug - 29 Dec 2022
    Consumer Medicine Information (CMI) about Feldene and Feldene-D intended for persons living in Australia.
  • Dysport
    Drug - 23 Dec 2022
    Consumer Medicine Information (CMI) about Dysport intended for persons living in Australia.
  • BeneFIX
    Drug - 20 Dec 2022
    Consumer Medicine Information (CMI) about BeneFIX intended for persons living in Australia.
  • Hyqvia
    Drug - 19 Dec 2022
    Consumer Medicine Information (CMI) about Hyqvia intended for persons living in Australia.
  • Nuelin Syrup
    Drug - 15 Dec 2022
    Consumer Medicine Information (CMI) about Nuelin Syrup intended for persons living in Australia.
  • Alunbrig
    Drug - 7 Dec 2022
    Consumer Medicine Information (CMI) about Alunbrig intended for persons living in Australia.
  • Avamys
    Drug - 7 Dec 2022
    Consumer Medicine Information (CMI) about Avamys intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback